CLINICAL_TRIALS
trial_result
· 2013-03-15
Clinical Trial Update: A Study of E7389 in Advanced/Metastatic Breast Cancer Patients [Phase 2]
Summary
Phase 2 clinical trial evaluating eribulin (E7389) for advanced or metastatic breast cancer; results from the study were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-03-15